Canaccord Genuity analyst Kyle Rose notes that “within an period of narrow networks and greater Opposition for patient volumes (from both equally hospitals and physicians), new and impressive technologies (not less than while in the eyes of possible people) may be worthwhile investments purely from the marketing standpoint.”Cid Highwind